Ticker LaunchIPO · RYZB
RayzeBio, Inc.
RayzeBio, Inc. (RYZB) priced its initial public offering on Sep 18, 2023 at $18.00 per share, within its $16.00–$18.00 range, raising $311M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $1.05B. J.P. Morgan was lead-left underwriter, joined by Jefferies, Evercore ISI and Truist. Cooley advised the company and Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- RYZB
- Exchange
- Nasdaq Global Market
- Priced
- Sep 18, 2023
- IPO price
- $18.00
- Price range
- $16.00–$18.00
- Raised
- $311M
- Market cap at IPO price
- $1.05B
- First filed
- Aug 24, 2023
- Underwriters
- J.P. Morgan, Jefferies, Evercore ISI and Truist
- Company counsel
- Cooley
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Aug 24, 2023
- Latest amendment Sep 11, 2023
- Final prospectus (424B4) Sep 18, 2023
- All filings on EDGAR CIK 1825367
Other Biotech & pharma IPOs in 2023
- CARGO Therapeutics, Inc.CRGX · Nov 13, 2023 · $281.2M
- Lexeo Therapeutics, Inc.LXEO · Nov 6, 2023 · $100M
- Abivax S.A.ABVX · Oct 23, 2023 · $235.8M
- Neumora Therapeutics, Inc.NMRA · Sep 18, 2023 · $250.1M
- Mira Pharmaceuticals, Inc.MIRA · Aug 4, 2023 · $8.9M
- Turnstone Biologics Corp.TSBX · Jul 24, 2023 · $80M